IRCT20201105049278N1CompletedPhase 3
Evaluation of the effectiveness of topiramate in comparison with acetazolamide in ?children with external hydrocephalus
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 3 months to 9 months (—)
- Sex
- All
Inclusion Criteria
- •Being between 3 and 9 months old
- •Final diagnosis of external hydrocephalus based on clinical evidence and brain imaging
- •Normal status of cognitive motor development (based on interview and clinical examination)
Exclusion Criteria
- •Having a brain tumor and subdural hematoma
- •Symptoms of increased intracranial pressure
- •Abnormal cognitive motor development
- •Existence of internal hydrocephalus
Investigators
Similar Trials
Recruiting
Phase 2
Evaluation of the effectiveness of topiramate in treating dependence of amphetamine and methamphetamine patientsIRCT20160417027437N2Ahvaz University of Medical Sciences60
Not yet recruiting
Phase 4
Randomized Trial for Comparison between amitriptyline alone and amitriptyline with topiramate combination in chronic migraine ,whether single drug is better or combination of these 2 drugsCTRI/2021/05/033356Principal Investigator Prof Jayantee Kalita
Completed
Phase 2
Ferrous sulfate in migraine headaches of childreMigraine.MigraineIRCT201504042639N15Research Deputy of Shahid Sadoughi University of Medical Sciences , Yazd, Iran60
Completed
Phase 2
Efficacy of topiramate and topiramate with omega-3 fatty acid in prophylaxis of children migraine headachesmigraine headache.MigraineIRCT20091027002639N23Yazd University of Medical Sciences60
Completed
Phase 2
Efficacy of topiramate alone and topiramate with supplement vitamin D3 on migraine headaches in 5-15 year old migraineur childreMigraine.MigraineIRCT201701092639N20Shahid Sadoughi University of Medical Sciences, Yazd, Iran60